Stockscreener 앱 받기
6.82
3.18%
0.21
시간 외 거래:
6.76
-0.06
-0.88%
전일 마감가:
$6.61
열려 있는:
$6.69
하루 거래량:
12,509
Relative Volume:
0.02
시가총액:
$3.91M
수익:
$856.00K
순이익/손실:
$-12.56M
주가수익비율:
-0.0295
EPS:
-231.4926
순현금흐름:
$-4.14M
1주 성능:
+1.19%
1개월 성능:
+45.11%
6개월 성능:
+23.62%
1년 성능:
-85.80%
1일 변동 폭
$6.48
$6.84
1주일 범위
$6.48
$7.43
52주 변동 폭
$2.98
$80.10
Scisparc Ltd Stock (SPRC) Company Profile
Compare SPRC vs VRTX, REGN, ARGX, RVMD, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SPRC
Scisparc Ltd
|
6.82 | 2.87M | 856.00K | -12.56M | -4.14M | -231.49 |
VRTX
Vertex Pharmaceuticals Inc
|
529.65 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
797.00 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
864.74 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
205.55 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
359.27 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Scisparc Ltd 주식(SPRC)의 최신 뉴스
Scisparc Ltd (SPRC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Scisparc Ltd (SPRC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
SciSparc shifts focus to agentic AI market - Investing.com
Scisparc Ltd (SPRC) Balance Sheet - TradingKey
Scisparc Ltd (SPRC) Institutional Confidence - TradingKey
SciSparc shifts focus to agentic AI market By Investing.com - Investing.com Canada
SciSparc targets agentic AI market and forms ad... - Pluang
Scisparc Ltd (SPRC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
SciSparc Ltd. Targets Agentic AI Market and Plans Scientific Advisory Board for AI and Cybersecurity - Quiver Quantitative
SciSparc discusses agentic AI opportunities with several companies - Stock Titan
Scisparc Ltd (SPRC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Scisparc Ltd (SPRC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
SciSparc Ltd. Revenue Breakdown – NASDAQ:SPRC - TradingView
SPRC|Scisparc Ltd|Price:5.330|Chg%:-0.390 - TradingKey
SciSparc Company Profile & Introduction - Moomoo
Scisparc Ltd (SPRC) Income Statement - TradingKey
SciSparc (SPRC) Stock Forecast & Analyst Ratings - Moomoo
SciSparc(SPRC) Stock Options Chain | Quotes & News - Moomoo
SciSparc Ltd. (Nasdaq: SPRC) starts Phase IIb SCI-110 trial for Tourette - Stock Titan
NeuroThera starts Phase IIb trial in Germany fo... - Pluang
SciSparc Subsidiary NeuroThera Initiates Phase IIb SCI-110 Clinical Trial Site at Hannover Medical School for Adult Tourette Syndrome - Quiver Quantitative
SciSparc: NeuroThera Labs Announces Initiation of Phase IIb - GlobeNewswire
NeuroThera Labs Announces Initiation of Phase IIb Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome - TheNewswire
Tourette treatment candidate SCI-110 enters testing at Hannover Medical School - Stock Titan
SciSparc (SPRC) Slips Over 7%: Support at $4.11 in Focus After Sharp DeclineWeak Sell Signals - dars.gov.et
SciSparc Ltd. (SPRC) details Alon Dayan RSUs and option in ownership update - Stock Titan
SciSparc Ltd. (SPRC) CEO Adler Oz updates Form 3 insider equity details - Stock Titan
SciSparc Ltd. (SPRC) director details RSU and option holdings in Form 3/A - Stock Titan
SciSparc Ltd. (SPRC) director revises Form 3, detailing RSU and option holdings - Stock Titan
SciSparc Ltd. (SPRC) CTO clarifies 5,528 RSU-linked shares and option terms - Stock Titan
SciSparc Ltd. (SPRC) director amends Form 3, details 3,649-share stake - Stock Titan
SciSparc Ltd. (SPRC) Tumbles 13.8% — Support Test in FocusRelative Volume - dars.gov.et
SciSparc Ltd. (SPRC) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
SciSparc (SPRC) Surges Over 10% as Trading Activity Picks UpOrder Block - dars.gov.et
SPRC Stock Price, Quote & Chart - ChartMill
NeuroThera Labs Announces Upsize to Private Placement - TheNewswire
NeuroThera Labs Announces C$5,000,000 Private Placement of Units - TheNewswire
SciSparc (SPRC) Drops 6.7% as Shares Approach Critical Support ZoneETF Creation Redemption - dars.gov.et
Form 144 SciSparc Ltd. For: 22 June By Investing.com - Investing.com Australia
[144] SciSparc Ltd. SEC Filing - Stock Titan
SciSparc (SPRC) Suffers Sharp Decline: Key Support Levels Under PressureVolume Breakout Ideas - dars.gov.et
Scisparc Ltd (SPRC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Scisparc Ltd (SPRC) Valuation: PE, PB & Fair Value Analysis - TradingKey
SPRC News | SCISPARC LTD (NASDAQ:SPRC) - ChartMill
Scisparc Ltd (SPRC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
SciSparc Ltd. (SPRC) Slips 2.46% as Shares Test Near-Term Support at $7.92Long Setup Ideas - dars.gov.et
SciSparc Ltd. Ordinary Shares Stock Short Interest Rises to 66.94% - Moomoo
SciSparc Ltd.'s Equity Buyback announced on July 7, 2022, has expired. - marketscreener.com
Why is SciSparc stock skyrocketing on Thursday? - MSN
SciSparc more than doubles as NeuroThera wins conditional nod for CliniQuantum deal - MSN
NeuroThera completes acquisition of 54% stake in CliniQuantum - Investing.com UK
Scisparc Ltd (SPRC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Scisparc Ltd 주식 (SPRC) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Shrem Itschak | Director |
Jun 01 '26 |
Sale |
10.00 |
462 |
4,620 |
10,596 |
0.39%
1.94%
자본화:
|
볼륨(24시간):